Search Results - "Germain, Matthieu"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Delivering the power of nanomedicine to patients today by Germain, Matthieu, Caputo, Fanny, Metcalfe, Su, Tosi, Giovanni, Spring, Kathleen, Åslund, Andreas K.O., Pottier, Agnes, Schiffelers, Raymond, Ceccaldi, Alexandre, Schmid, Ruth

    Published in Journal of controlled release (10-10-2020)
    “…The situation of the COVID-19 pandemic reminds us that we permanently need high-value flexible solutions to urgent clinical needs including simplified…”
    Get full text
    Journal Article
  2. 2
  3. 3

    A Nanoprimer To Improve the Systemic Delivery of siRNA and mRNA by Saunders, Nell R M, Paolini, Marion S, Fenton, Owen S, Poul, Laurence, Devalliere, Julie, Mpambani, Francis, Darmon, Audrey, Bergère, Maxime, Jibault, Océane, Germain, Matthieu, Langer, Robert

    Published in Nano letters (10-06-2020)
    “…Despite tremendous interest in gene therapies, the systemic delivery of nucleic acids still faces substantial challenges. To successfully administer nucleic…”
    Get full text
    Journal Article
  4. 4

    Abstract 3613: Mononuclear phagocytic system occupancy to increase nanomedicines based treatment efficacy by germain, matthieu, Poul, Laurence, Devalliere, Julie, Paolini, Marion, Darmon, Audrey, Bergere, Maxime, Jibault, Oceane, Mpambani, Francis

    Published in Cancer research (Chicago, Ill.) (01-07-2019)
    “…Abstract Introduction: To efficiently deliver treatment, nanomedicines must exhibit sufficient blood bioavailability for further accumulation at the target…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Abstract 3902: The Nanoprimer: A significant opportunity to boost the efficacy of cancer therapies by Devallière, Julie, Poul, Laurence, Bergère, Maxime, Mpambani, Francis, Darmon, Audrey, Jibault, Océane, Germain, Matthieu

    Published in Cancer research (Chicago, Ill.) (22-03-2024)
    “…Abstract Nanomedicines are among the most promising novel delivery systems and are highly promising as therapeutic agents in oncology. However, their use is…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Abstract LB-072: Redefine nanomedicine products bioavailability to improve anti-tumor efficacy by Germain, Matthieu, Poul, Laurence, Meyre, Marie-Edith, Paolini, Marion, Mpambani, Francis, Bergere, Maxime, Pottier, Agnes, Levy, Laurent

    Published in Cancer research (Chicago, Ill.) (01-07-2018)
    “…Abstract Introduction: The benefit of a nanomedicine is due to its bioavailability, its intrinsic efficacy balanced with its toxicity profile. The nanomedicine…”
    Get full text
    Journal Article
  9. 9

    A new opportunity for nanomedicines: Micellar cytochrome P450 inhibitors to improve drug efficacy in a cancer therapy model by Paolini, Marion, Poul, Laurence, Darmon, Audrey, Germain, Matthieu, Pottier, Agnès, Levy, Laurent, Vibert, Eric

    Published in Nanomedicine (01-07-2017)
    “…Abstract Nanomedicines are mainly used as drug delivery systems; here we evaluate a new application - to inhibit a drug's metabolism thereby enhancing its…”
    Get full text
    Journal Article
  10. 10

    Abstract 3295: The Nanoprimer: A nanoparticle designed to the efficacy of nucleic acid-based therapeutics in oncology by Devallière, Julie, Poul, Laurence, Bergère, Maxime, Darmon, Audrey, Jibault, Océane, Mpambani, Francis, Tsai, Kelvin, Germain, Matthieu

    Published in Cancer research (Chicago, Ill.) (15-06-2022)
    “…Abstract Nucleic acid drugs have shown promise in oncology, however their use is limited by hepatic clearance. Due to the mononuclear phagocytic system (MPS),…”
    Get full text
    Journal Article
  11. 11

    Priming the body to receive the therapeutic agent to redefine treatment benefit/risk profile by Germain, Matthieu, Meyre, Marie-Edith, Poul, Laurence, Paolini, Marion, Berjaud, Céline, Mpambani, Francis, Bergere, Maxime, Levy, Laurent, Pottier, Agnès

    Published in Scientific reports (19-03-2018)
    “…Many therapeutic agents offer a low useful dose (dose responsible for efficacy)/useless dose (dose eliminated or responsible for toxicity) ratio, mainly due to…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Nano-sized cytochrome P450 3A4 inhibitors to block hepatic metabolism of docetaxel by Paolini, Marion, Poul, Laurence, Berjaud, Céline, Germain, Matthieu, Darmon, Audrey, Bergère, Maxime, Pottier, Agnès, Levy, Laurent, Vibert, Eric

    Published in International journal of nanomedicine (01-01-2017)
    “…Most drugs are metabolized by hepatic cytochrome P450 3A4 (CYP3A4), resulting in their reduced bioavailability. In this study, we present the design and…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Protection of mammalian cell used in biosensors by coating with a polyelectrolyte shell by Germain, Matthieu, Balaguer, Patrick, Nicolas, Jean-Claude, Lopez, Frederic, Esteve, Jean-Pierre, Sukhorukov, Gleb B., Winterhalter, Mathias, Richard-Foy, Hélène, Fournier, Didier

    Published in Biosensors & bioelectronics (15-02-2006)
    “…In order to detect xenoestrogens which induce perturbations of mammalian cells, design of biosensor using a mammalian cell line enable to detect these…”
    Get full text
    Journal Article
  16. 16

    Ultrasound-induced temperature elevation for in-vitro controlled release of temperature-sensitive liposomes by Mannaris, Christophoros, Efthymiou, Eleni, Escoffre, Jean-Michel, Bouakaz, Ayache, Meyre, Marie-Edith, Germain, Matthieu, Averkiou, Michalakis A.

    “…Drug loaded temperature-sensitive liposomes (TSLs) release their payload with mild hyperthermia near their phase transition temperature (Tm = 43–45 °C). Such a…”
    Get full text
    Journal Article
  17. 17

    Composite Nanocapsules: Lipid Vesicles Covered with Several Layers of Crosslinked Polyelectrolytes by Germain, M., Grube, S., Carriere, V., Richard-Foy, H., Winterhalter, M., Fournier, D.

    Published in Advanced materials (Weinheim) (03-11-2006)
    “…Biologically active proteins are loaded into liposomes, which are then used as templates for the layer‐by‐layer deposition of polyelectrolytes. The multilayer…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Inactivation of the 3′-5′ Exonuclease of the Replicative T4 DNA Polymerase Allows Translesion DNA Synthesis at an Abasic Site by Le Gac, Nicolas Tanguy, Delagoutte, Emmanuelle, Germain, Matthieu, Villani, Giuseppe

    Published in Journal of molecular biology (05-03-2004)
    “…Here, we have investigated the consequences of the loss of proof-reading exonuclease function on the ability of the replicative T4 DNA polymerase (gp43) to…”
    Get full text
    Journal Article
  20. 20

    Liposome-based nanocapsules by Ruysschaert, T., Germain, M., da Silva Gomes, J.F.P., Fournier, D., Sukhorukov, G.B., Meier, W., Winterhalter, M.

    Published in IEEE transactions on nanobioscience (01-03-2004)
    “…Here we present three different types of mechanically stable nanometer-sized hollow capsules. The common point of the currently developed systems in our…”
    Get full text
    Magazine Article